Astria Therapeutics, Inc. (ATXS) Tops Q1 EPS by 17c

Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q1 EPS of ($0.40), $0.17 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15